Bruce Crowther

Track

Insider profile

Currently holds positions in Wintrust Financial Corp, Neogenomics Inc and Methode Electronics Inc

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return -11% 8.2% 15.1%
Success rate 2% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Wintrust Financial Corp Jan. 1, 1998 -
Independent Director Neogenomics Inc Oct. 27, 2014 -
Independent Director Methode Electronics Inc June 13, 2019 -
Bruce Crowther's trades of Neogenomics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
495.90
Quantity 40,444
Value US$4,108,014
Transaction date
Proposed sale
Price
226.54
Quantity 66,879
Value US$260,153
Transaction date
Sale
Price
383.79
Quantity 73,522 +40.6%
Value US$3,727,543
Transaction date
Sale
Price
35.01
Quantity 8,333 -15.2%
Value US$291,738
Transaction date
Sale
Price
35.68
Quantity 2,400 -4.9%
Value US$85,632
Transaction date
Purchase
Price
31.58
Quantity 900 +30.0%
Value US$28,418
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-15 2024-08-15
PrS Proposed sale
40,444
495.90
US$4,108,014 		40,444 495.90 US$4,108,014
2024-05-28 2024-05-28
PrS Proposed sale
66,879
226.54
US$260,153 		66,879 226.54 US$260,153
2021-06-10 2021-06-08
S Sale
73,522 +40.6%
383.79
US$3,727,543 		73,522 +40.6% 383.79 US$3,727,543
2020-09-24 2020-09-24
S Sale
8,333 -15.2%
35.01
US$291,738 		8,333 -15.2% 35.01 US$291,738
2020-09-24 2020-09-22
S Sale
2,400 -4.9%
35.68
US$85,632 		2,400 -4.9% 35.68 US$85,632
2019-09-06 2019-09-04
B Purchase
900 +30.0%
31.58
US$28,418 		900 +30.0% 31.58 US$28,418